|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
on1206399033 |
| 003 |
OCoLC |
| 005 |
20240623213015.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
201114s2020 si o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d YDX
|d EBLCP
|d LOA
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCL
|d SXB
|
| 019 |
|
|
|a 1202224741
|
| 020 |
|
|
|a 9789811428395
|
| 020 |
|
|
|a 9811428395
|
| 035 |
|
|
|a (OCoLC)1206399033
|z (OCoLC)1202224741
|
| 050 |
|
4 |
|a RM666.A5
|b .F766 2020
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Atta-ur-Rahman.
|
| 245 |
1 |
0 |
|a Frontiers in Clinical Drug Research - Anti-Allergy Agents
|h [electronic resource].
|
| 260 |
|
|
|a Singapore :
|b Bentham Science Publishers,
|c 2020.
|
| 300 |
|
|
|a 1 online resource (179 p.).
|
| 490 |
1 |
|
|a Frontiers in Clinical Drug Research - Anti-Allergy Agents Ser.
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 520 |
|
|
|a Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The fourth v.
|
| 505 |
0 |
|
|a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Anti-inflammatory and Immunomodulatory Pro-perties of Medicinal Plant Products -- Abdelhakim Bouyahya* and Youssef Bakri -- INTRODUCTION -- MEDICINAL PLANTS BIOACTIVE MOLECULES -- Terpenes -- Polyphenols -- Flavonoids -- Alkaloids -- ANTI-INFLAMMATORY EFFECTS OF MEDICINAL PLANT PRODUCTS -- IMMUNOMODULATORY EFFECTS OF MEDICINAL PLANT PRODUCTS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES
|
| 505 |
8 |
|
|a Helminth Therapy: A New Tool for Treatment of Allergic Diseases -- Dalia S. Ashour* -- INTRODUCTION -- Hygiene Hypothesis -- Allergy -- Allergic Immune Response -- Host Immune Response to Helminth Infection -- Regulatory Mechanisms in Helminth Infection -- Immune Response for Combined Helminth Infections and Allergic Diseases -- Positive Association of Some Helminths with Allergic Diseases -- Factors Affecting the Effect of Helminth Infection on Allergic Diseases -- Different Helminths Species -- Type of the Host (Definitive vs Accidental Host) -- Timing and Chronicity of Infection
|
| 505 |
8 |
|
|a Intensity of Infection -- Host Genetics -- The Concept of Helminth Therapy -- Role of Helminth-derived Products in Protection from Allergy -- General HDP -- Cytokine Homologue -- Protease Inhibitors -- ES-62 -- Species-specific HDP -- Ascaris suum-derived Antigens -- Current Status of Helminthic Therapy in Allergic Diseases -- Challenges of Helminth Therapy -- Ethical Considerations -- Practical Considerations -- CONCLUSIONS AND FUTURE PERSPECTIVES -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES
|
| 505 |
8 |
|
|a An Overview of Anti-Allergic Medications in Paediatric Population -- Edwin Dias1,* and Anusha Leah Dias2 -- INTRODUCTION -- DRUGS USED IN ALLERGIC DISEASES -- H1 Antihistamines -- Leukotriene Inhibitors -- Th2 Cytokine Inhibitors -- Corticosteroids -- TYPES OF MEDICATIONS -- Corticosteroids -- Antihistamines -- Other Allergy Medications -- Immunotherapy -- Seasonal Allergy Treatments -- ALLERGIC DISEASES TREATMENT -- Allergic Rhinitis -- Allergic Conjunctivitis -- Atopic Dermatitis -- Food Allergy -- Anti-Allergic Medications -- BRONCHIAL ASTHMA -- Antiallergic Medications
|
| 505 |
8 |
|
|a Management of Steroid-Resistant Asthma -- Newer Drugs in Asthma Control -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- In-Silico Approaches in Drug Discovery and Design of Antiallergic Agents -- Purusottam Banjare, Ajay Singh Sarthi, Jagadish Singh and Partha Pratim Roy* -- INTRODUCTION -- PATHOPHYSIOLOGY OF ALLERGY REACTION -- TARGETS ASSOCIATED WITH ALLERGY -- Histamine -- Leukotrienes and Lipoxygenases (LOXs): -- Thromboxane A2 -- Interleukin -- Mast Cells -- Other Targets -- IN SILICO METHODS USED IN DRUG DISCOVERY PROCESS
|
| 650 |
|
0 |
|a Antiallergic agents.
|
| 650 |
|
0 |
|a Anti-inflammatory agents.
|
| 650 |
|
7 |
|a Anti-inflammatory agents
|2 fast
|
| 650 |
|
7 |
|a Antiallergic agents
|2 fast
|
| 758 |
|
|
|i has work:
|a Frontiers in Clinical Drug Research Volume 3 Anti-Allergy Agents (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGc6889kxGRHd6pJXphcrm
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Atta-ur-Rahman
|t Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 4
|d Singapore : Bentham Science Publishers,c2020
|z 9789811428388
|
| 830 |
|
0 |
|a Frontiers in Clinical Drug Research - Anti-Allergy Agents Ser.
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=6388631
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|